Background: Heavy and chronic ethanol (EtOH) exposure can cause significant structural and functional damage to the adult brain. The most devastating consequence of EtOH exposure is the neurotoxicity associated with the depletion of neurons. Regulation of splice variants in the brain can modulate protein functions, which may ultimately affect behaviors associated with alcohol dependence and EtOH-mediated neurotoxicity. As alcohol consumption is associated with neurotoxicity, it is possible that altered splicing of survival and pro-survival factors during the development of alcoholism may contribute to the neurotoxicity.
H
EAVY AND CHRONIC ethanol (EtOH) consumption can cause significant structural and functional damage to the brain. Many studies have shown that heavy alcohol exposure leads to neurodegeneration in the mature brain (Luo, 2014; de la Monte and Kril, 2014; Tiwari and Chopra, 2013) . The developing nervous system is even more vulnerable to EtOH exposure. Prenatal exposure to EtOH during pregnancy can cause fetal alcohol spectrum disorders (FASD), characterized by malformation of the nervous system, deficits in craniofacial development, growth deficiencies, and mental retardation (May et al., 2009; Riley et al., 2011; Sampson et al., 2000) . FASD incidence in the United States is nearly 5% (May et al., 2009) , and estimated lifetime cost of FASD was over $2 million per case in 2004 (Lupton et al., 2004) . The most devastating consequence of developmental exposure to EtOH is the neurotoxicity associated with the depletion of neurons in the developing brain. Therefore, it is crucial to elucidate the mechanisms of neuroapoptosis induced by EtOH exposure in order to develop effective therapeutic strategies to overcome EtOH-induced neurotoxicity.
Alternative pre-mRNA splicing makes a large and significant contribution to proteomic diversity. Utilization of various potential splice sites of the pre-mRNA in various combinations by spliceosome in the guidance of alternative splicing regulatory factors leads to the translation of several functionally distinct protein isoforms. Regulation of splice variants in the brain can modulate protein functions, which may ultimately affect behaviors associated with alcohol dependence and alcohol-mediated neurotoxicity. A limited number of studies has shown that the pre-mRNA splicing patterns of genes are potentially altered during the development of alcoholism (Farris and Mayfield, 2014; Sasabe and Ishiura, 2010) . EtOH exposure in experimental animals has been reported to alter pre-mRNA splicing of the dopamine D2 receptor (DRD2) (Oomizu et al., 2003) , the NR1 subunit of the NMDA receptor (Hardy et al., 1999; Laurie et al., 1995) , and the c2 subunit of the GABAA receptor (Petrie et al., 2001) . Altered splicing of these receptor units during the development of alcoholism was mainly proposed to be involved in behavior changes, such as alcohol dependence. Many intriguing questions remain to be answered, such as how alcohol affects splicing and splicing regulatory proteins. As alcohol consumption is associated with neurotoxicity, it is possible that altered splicing of survival and pro-survival factors during the development of alcoholism may contribute to the neurotoxicity associated with EtOH exposure.
Here we investigated the possible impact of EtOH exposure on expression of alternative splicing factors and the alternative splicing of candidate genes in neurons. Our data indicate that the anti-apoptotic Mcl-1L isoform is the major form of Mcl-1 expressed in primary human fetal neurons (PHFNs). Moreover, our data suggest that EtOH exposure of primary neurons suppresses expression levels of argininerich splicing factor 1 (SRSF1) and causes a decrease in the ratio of Mcl-1L/Mcl-1S by favoring the pro-apoptotic Mcl-1S splicing over anti-apoptotic Mcl-1L, suggesting that Mcl-1S may play a crucial role in neurotoxicity associated with alcohol consumption.
MATERIALS AND METHODS

Ethics Statement
All primary human cells were obtained and utilized in accordance with Temple University Human Subjects Protections and the approval of the Institutional Review Board.
Plasmids and Constructs
pcDNA3.1-Mcl-1L plasmid encoding human Mcl-1L isoform was reported previously (Morel et al., 2009) and obtained from Addgene (#25375; Cambridge, MA). The luciferase reporter plasmid pLuc-SRSF1 was made by cloning the À1,000 to +49 promoter region of SRSF1 gene into the pGL3 vector at the BamH1 site and was described previously Sariyer et al., 2016) . Human SRSF (NCBI Reference Sequence: NM_006924.4) was cloned into the eukaryotic expression vector pcDNA TM 6/myc-His at Hind-III and Xho-I restriction enzyme sites and labeled as pcDNA TM 6/myc-His-SRSF1. The plasmid was created with the following primers: SRSF1-F: 5 0 -AAGATTAAGCTTATGTCGG GAGGTGGTGTG-3 0 and SRSF1-R: 5 0 -AAGATTCTCGAGTG TACGAGAGCGAGATCT-3 0 .
Antibodies and Reagents
Antibodies were obtained from the following sources: anti-MAP2, anti-beta-tubulin, and antisynaptophysin from Cell Signaling Inc. (Beverly, MA); b-tubulin from LI-COR, Odyssey (LI-COR Biotechnology, Lincoln, NE); anti-SRSF1 from Invitrogen/Thermo Fisher Inc. (Waltham, MA); anti-SRSF2 from Sigma-Aldrich (St. Louis, MO); anti-Mcl-1, anti-SRSF3, anti-SRSF4, and anti-HNRNP A1 from Santa Cruz Biotech (Dallas, TX); and anti-Grb2 from BD Biosciences (San Jose, CA). Mammalian protease inhibitors were obtained from Sigma-Aldrich. Bradford reagent was from BioWorld (Dublin, OH). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was obtained from ThermoFisher Scientific (#M6494; Waltham, MA).
Cell Culture
Cultures of PHFN were described previously (Saribas et al., 2017) . Briefly, PHFNs were obtained in 6-well plates or 2-well chamber slides from the Comprehensive NeuroAIDS Center tissue culture core at Temple University Lewis Katz Medical School. Cells were maintained in Neurobasal medium (Gibco/Thermo Fisher Inc., Waltham, MA) containing B-27 supplement (Gibco), 0.05% GlutaMAX TM (Gibco), and gentamicin (10 lg/ml) at 37°C under 5% CO 2 . Half of the neuronal growth medium was replaced with fresh medium every 3 to 4 days. SH-SY5Y neuroblastoma cells were obtained from American Tissue Culture Collection (ATCC Ò CRL-2266 TM ; Manassas, VA). They were plated in the poly-D-lysinecoated 6-well dishes and maintained in growth medium [Dulbecco's Modified Eagle Medium (DMEM): F12 medium supplemented with 10% fetal bovine serum (FBS), 10% GlutaMAX TM (ThermoFisher Scientific), insulin, and gentamicin (10 lg/ml)] at 37°C under 5% CO 2 atmosphere. The growth medium was changed every 3 to 4 days.
EtOH Anti-Evaporation Chambers
To maintain constant EtOH concentrations in cell culture media, we utilized an "anti-evaporation system" adopted from Eysseric and colleagues (1997) and Rodr ıguez and colleagues (1992) with some modifications. Briefly, primary human neurons were exposed to 50 mM EtOH and placed in a polystyrene box with a lid which allowed the CO 2 transport. In addition, an open pan with 50 mM EtOH was also placed into the polystyrene box in advance to saturate the evaporated EtOH in the polystyrene box that limited EtOH evaporation from the media of cultured neurons.
EtOH Assay
EtOH concentrations in culture media were determined using a commercial kit (Sigma-Aldrich #MAK076) according to the manufacturer's instructions.
MTT Assay for Cell Viability
PHFN or SH-SY5Y cells were plated in 6-well tissue culture plates (2 9 10 5 ) and treated with various concentrations of EtOH. Twenty-four hours post treatment, cells were incubated with 1 ml of MTT working solution (DMEM with 0.5 mg/ml MTT) for 2 hours at 37°C. The converted dye was solubilized with 1 ml acidic isopropanol (0.004 M HCl in isopropanol). The absorbance of the converted dye was measured at a wavelength of 570 nm with background subtraction at 650 nm.
Alternative Splicing Analysis and RT-PCRs SH-SY5Y and PHFN cells were exposed to 50 mM EtOH in a polystyrene box to prevent EtOH evaporation, adopted from Eysseric and colleagues (1997) and Rodr ıguez and colleagues (1992) . At various postexposure time points, cells were harvested, and total RNA was extracted with an RNA extraction kit (RNeasy; Qiagen, Germantown, MD) according to the manufacturer's instructions. RT-PCRs were performed as described previously (De-Simone et al., 2015) . After treatment with DNase I, followed by phenol/ chloroform extraction and EtOH precipitation, cDNAs were synthesized using M-MuLV reverse transcriptase. RNA templates were removed by RNase H digestion. A total of 100 ng cDNA was used as template for PCRs. Alternatively spliced isoforms of BIM, RON, Mcl-1, and BIN1 genes were amplified by PCR using specific primers listed in Table 1 . b-Actin mRNA was also amplified from the same set of RNA samples by RT-PCR as an internal control. Amplified gene products were resolved on a 2% DNA-agarose gel.
Immunocytochemistry
PHFNs were cultured in 2-well chamber slides (2 9 10 5 cells/ well). PHFNs were either exposed to 50 mM EtOH or left untreated. Immunocytochemistry was performed as described previously (Merabova et al., 2015) . Briefly, at 24 hours postexposure, neurons were fixed with cold Acetone:MetOH (50:50) for 1 minute, washed 3 times with PBS and then blocked with 10% BSA in phosphate-buffered saline (PBS) for 1 hour, and incubated with rabbit polyclonal anti-MAP-2 and mouse monoclonal antisynaptophysin antibodies. Primary antibody dilutions were 1:300 in 5% BSA overnight at 4°C with gentle rocking. After primary antibody incubation, cells were washed 3 times with PBS and then incubated with a secondary solution containing 1:500 FITC rabbit secondary and 1:500 rhodamine mouse secondary, in 5% BSA for 2 hours. Wells were then washed 5 times with PBS and mounted with Vectashield mounting solution containing DAPI. Then, glass coverslips were added before imaging on a Leica Fluorescence Microscope (Leica Microsystems Inc., Buffalo Grove, IL).
Preparation of the PHFN and SH-SY5Y Cell Lysates, and SDS-PAGE/Western Blotting PHFN and SH-SY5Y lysates were prepared using TNN buffer with 1% NP40 supplemented as described previously (Saribas et al., , 2017 . Briefly, the cell lysates were prepared as follows. At the end of incubations, cells were washed in PBS and harvested by trypsinization. Cells were then lysed in TNN buffer with 1% NP40 supplemented with mammalian protease and phosphatase inhibitors, 0.4 mM NaF and 2 mM Na 3 VO 4. Protein concentrations were determined by Bradford Protein Quantification assay. Protein samples were first denatured in SDS loading dye, heated at 95°C for 5 minutes, and then separated on 10% SDS-PAGE. After electrophoresis, proteins were transferred to 0.45 lm nitrocellulose membranes for 2 hours at 250 mA, alternatively overnight at 40 mA in 19 cold transfer buffer (100 mM Tris-HCl, pH 7.4, 150 mM NaCl, 20% MEOH). Membranes were blocked in either 19 PBST buffer containing 10% milk or 19 LI-COR blocking buffer for at least 1 hour at room temperature. The primary monoclonal antibodies, anti-SRSF1, anti-SRSF2, anti-SRSF3, anti-SRSF4, anti-HNRNP A1, anti-Mcl-1, anti-Tubulin, and anti-Grb2 were diluted 1/1,000 in buffer containing 5% milk and added to membranes where needed and were incubated overnight at 4°C with gentle shaking. After washing the membranes with 19 PBST buffer 3 times, the secondary antibodies [LI-COR Goat against Rabbit 680 for polyclonal, LI-COR Goat against Mouse 800 for monoclonal] were added to the membranes and incubated for 45 minutes at room temperature followed by 3 times (5 minutes) washing with 19 PBST buffer and a final wash with 19 PBS buffer. Washed membranes were stored in 19 PBS before scanning images on an Odyssey CLx (LI-COR Biotechnology). The intensity of each protein band was calculated using ImageJ (National Institute of Health, Bethesda, MD) software, and bar graphs were produced in Microsoft Excel (Microsoft Corp., Redmond, WA).
Stable Cell Lines
SH-SY5Y cells (1 9 10 5 cells/35 mm tissue culture dish) were either transfected with pcDNA3.1 vector alone (Invitrogen) or pcDNA3.1-hMcl-1L (2 lg/plate) using lipofectamine 2000 method according to the manufacturer's recommendations (Invitrogen). Stable clonal cell lines were generated as described previously (Sariyer et al., 2011) . Briefly, at 6 hours post transfection, cells were washed twice with PBS and re-fed with DMEM culture media containing 10% FBS. After 24 hours, cells from each 35-mm plate were trypsinized and re-plated onto three 100-mm plates. Cells were allowed to attach for 6 hours, and then, the medium was replaced with DMEM containing 800 lg/ml G418 and 10% FBS. The medium of the cells was replaced every 2 to 3 days until individual colonies formed. The single cell colonies were isolated and screened for MCL-1L overexpression by Western blot, expanded, and frozen in liquid nitrogen.
Luciferase Reporter Assay
PHFN or SH-SY5Y cells were plated in 6-well tissue culture dishes and transiently transfected with the pLuc-SRSF1 (À1,000 to +49) luciferase reporter plasmid. Cells were treated with increasing concentrations of EtOH (10, 25, 50, and 100 mM) in compensation chambers to prevent of EtOH evaporation. At 48 hours post transfection, cells were extracted and lysed using reporter lysis buffer for the luciferase reporter system provided by the manufacturer Promega (Madison, WI). After cell lysis, luciferase activities of samples were determined using luciferase assay reagent. The luciferase activities were then corrected for protein concentration and normalized to the basal levels of transcription, allowing the determination of the fold changes.
Statistical Analysis
All of the values presented on the graphs are given as means AE SEM. Analysis of variance and unpaired Student's t-tests were used to analyze the statistical significance. p-Values of <0.05 were considered statistically significant.
RESULTS
EtOH Exposure is Toxic to Neuronal Cells
To gain insight into the impact of EtOH exposure on neurons, PHFNs were plated in 6-well tissue culture dishes until they formed typical neuronal networks. Neurons were then treated with increasing concentrations of EtOH (0, 1, 10, 25, 50, and 100 mM) for 24 hours, and cell viabilities were determined by MTT assay. As seen in Fig. 1A , at low concentrations (1 and 10 mM), EtOH had no significant effect on neuronal viability. Interestingly, there was a mild but significant reduction in neuronal viability when cells were treated with 25 mM EtOH. Larger reductions in neuronal viability were observed with 50 and 100 mM EtOH treatments. These results have suggested that EtOH exposure is toxic to neurons at 25 mM or higher doses. In parallel to the PHFNs, we also analyzed the impact of EtOH exposure on the cellular viability of SH-SY5Y cells, a human neuroblastoma cell line. SH-SY5Y cells were exposed to 50 mM EtOH for 24 hours. Cellular viabilities were determined by MTT assay at 0, 8, and 24 hours postexposure. As shown in Fig. 1B , SH-SY5Y cells showed an increasing trend in cellular viability as expected due to the active replication and growth of the cells. On the other hand, SH-SY5Y cells which were exposed to EtOH not only lost their increasing trend of cell growth but also showed a significant reduction in their viability at 24 hours post treatment suggesting that EtOH exposure is also toxic to SH-SY5Y cells. To gain more insight into the effects of EtOH exposure on neurons, PHFN cells were also plated in chamber slides and exposed to EtOH for 24 hours. Cells were fixed and immunolabeled with neuronal Map2 and Synaptophysin markers. As shown in Fig. 1C , control neurons showed a typical staining of Map2 and synaptophysin with partial co-localization of both markers. Interestingly, EtOH exposure to PHFN cells caused a significant reduction in Map2 and even more significant decrease in synaptophysin staining in the majority of the neurons (Fig. 1C , compare control with EtOH). Together, these results suggest that EtOH exposure causes a significant toxicity to neuronal cells in a dose-dependent manner.
EtOH-Mediated Suppression of SRSF1 in Primary Human Neurons
Regulation of splice variants in neurons can modulate protein functions, which may ultimately contribute to alcoholmediated neurotoxicity. Alternative splicing is mainly regulated by a group of proteins that are classified as serine/ arginine-rich proteins (SR proteins). The SR proteins have been extensively studied and are known to play important roles in pre-mRNA splicing of cellular genes (Manley and Krainer, 2010) . To gain insight into the possible effect of EtOH exposure on SR protein expressions, PHFN cells were SH-SY5Y cells were plated in 6-well tissue culture dishes and exposed to 50 mM EtOH. MTT viability assay was performed at 0, 12, and 24 hours postexposure. Bar graph represents 3 replicates. The Student's t-test was performed to calculate p-values. (C) Effect of EtOH exposure on MAP2 and synaptophysin expression in primary human neurons. PHFN cells were plated in 2-well chamber slides and exposed to 50 mM EtOH. The cells were fixed at 24 hours postexposure and processed for immunocytochemistry for the detection of MAP2 and synaptophysin. *p < 0.05, **p < 0.02, ***p < 0.01. plated in 6-well tissue culture dishes and treated with 50 mM EtOH up to 48 hours. To gain an idea about dose-and time-dependent impact of EtOH on SR protein expression, EtOH evaporation was allowed during these treatments. At 4, 8, 24, 32, and 48 hours post treatment, whole cell protein extracts were collected and analyzed by Western blot for SRSF1, SRSF2, SRSF3, and HNRNP A1 expression. The culture media was also collected to monitor EtOH concentrations at various time points post treatment. As shown in Fig. 2A , there was a significant decrease in the expression levels of all the splicing regulatory proteins at 8 hours posttreatment. Interestingly, at 24 hours post treatment, when EtOH concentration in culture media dropped to <5 mM (Fig. 2B) due to the evaporation, expression levels of SRSF2, SRSF3, and HNRNP A1 were completely recovered and stayed stable at 32 and 48 hours post treatment. On the other hand, expression levels of SRSF1, which had the most dramatic decrease at 8 hours, never reached to the normal expression levels at 24, 32, and 48 hours post treatment even after EtOH concentration in culture media dropped below to 2 mM. To further analyze the effect of EtOH exposure on SRSF1 expression, PHFN cells were also exposed to EtOH using a "compensation system" to prevent EtOH evaporation, adopted from Eysseric and colleagues (1997) and Rodr ıguez and colleagues (1992) . As shown in Fig. 2C ,D, EtOH exposure caused a dramatic decrease in SRSF1 levels over time under constant level of exposure suggesting that EtOH inhibits SRSF1 expression in PHFN cells. Neither SRSF4 nor tubulin levels were altered by EtOH exposure.
EtOH-Mediated Alternative Splicing of Candidate Genes in Neuronal Cells
As shown above (Fig. 2) , EtOH exposure of PHFNs caused a dramatic decrease in the expression levels of SR family alternative splicing factors, particularly SRSF1. Next, we sought to investigate the effect of EtOH exposure on alternative splicing patterns of candidate genes which have been shown to be regulated by SRSF1 and involved in the regulation of apoptosis. Among the possible candidate genes, we analyzed the alternative splicing of Bcl-2-like protein 11 (BCL2L11 or BIM), macrophage-stimulating protein receptor (MST1R), bridging integrator 1 (BIN1), and myeloid cell leukemia-1 (Mcl-1) (Anczukow et al., 2012; Karni et al., Fig. 2 . Time-and dose-dependent effect of EtOH exposure on expression levels of splicing regulatory proteins. (A) PHFN cells were exposed to 50 mM EtOH, and whole cell protein extracts were prepared at 0, 4, 8, 24, 32, and 48 hours postexposure. Western blots of protein lysates were performed to access the expression levels of SRSF1, SRSF2, SRSF3, and HNRNP A1. Tubulin was probed in the same blots as a loading control. (B) EtOH concentrations in culture media in parallel to whole cell extracts were measured and shown as bar graph. (C) PHFN cells were exposed to 50 mM EtOH in evaporation compensation chambers, and whole cell protein extracts were prepared at 0, 24, and 48 hours postexposure. Western blots of whole cell protein extracts were performed to access the expression levels of SFSF1 and SRSF4. Tubulin was probed in the same blots as a loading control. (D) EtOH concentrations in culture media in parallel to whole cell extracts from the same studies described in panel C were measured and shown as bar graph.
2007; Khan et al., 2014) . SH-SY5Y cells were exposed to 50 mM EtOH for up to 8 hours. EtOH evaporation during treatment was controlled by "compensation system" as described in Materials and Methods. At 0, 1, 4, and 8 hours postexposure, total RNA was isolated from cells and analyzed by RT-PCR using dedicated primers to amplify all the possible spliced isoforms of the genes. As shown in Fig. 3 (left panel), SH-SY5Y cells express majorly the EL isoform of BIM and full-length isoform of MST1R genes. Interestingly, EtOH caused a shift in BIM splicing to c1 and c2 isoforms by 4 hours and delta-11 isoform in MST1R by 8 hours postexposure. More interestingly, EtOH exposure caused a significant switch in Mcl-1 alternative splicing from anti-apoptotic Mcl-1L isoform to pro-apoptotic Mcl-1S isoform in SH-SY5Y cells with no significant alteration in the alternative splicing pattern of BIN1 gene. In addition to SH-SY5Y cells, we have also analyzed and compared the effect of EtOH exposure on alternative splicing patterns of selected genes in PHFNs. PHFN cells were also exposed to 50 mM EtOH for up to 36 hours. EtOH evaporation during the treatments was controlled by "compensation system" as described in Materials and Methods. At 0, 1, 4, 8, 24, and 36 hours postexposure, total RNA was isolated from cells and analyzed by RT-PCR using specific primers. As shown in Fig. 3 Fig. 3 . EtOH-mediated alternative splicing of candidate genes in neurons. PHFN and SH-SY5Y cells were exposed to 50 mM EtOH for up to 36 hours. EtOH evaporation during the treatments was controlled by "compensation system." At each time point, total RNA was isolated from control cells (cont.) and from cells exposed to EtOH using the RNeasy extraction kit (Qiagen). One microgram of total RNA was used in reverse transcription reactions, and cDNA was synthesized. Splicing isoforms of BIM, MST1R, Mcl-1, and BIN1 were amplified by PCR using specific primers (Table 1) , and separated and monitored on agarose gel by ethidium bromide staining. Alternative splicing isoforms of the proteins are indicated by arrows. The location of primer pairs and map of exon-intron structure of the genes are schematized in the right-hand panels. 50 mM EtOH for 24 hours. Cell viabilities were determined by MTT assay. As shown in Fig. 4A , EtOH caused~50% decrease in neuronal viability (lane 2) as expected. Interestingly, ectopic expression of Mcl-1L completely recovered the neuronal viability suppressed by EtOH exposure, suggesting that Mcl-1L isoform can protect primary neurons against EtOH-induced neurotoxicity. To gain more insight into the neuroprotection by Mcl-1L, we obtained clonal cell line derivatives of SH-SY5Y cells, which stably express the Mcl-1L isoform. SH-SY5Y cells were transfected with either pcDNA3.1 vector alone or pcDNA 3.1-Mcl-1L. Stable clonal cells were selected by G418 treatment and cloned by limiting dilution. As shown in Fig. 4B , control cells showed a significant reduction in cell viability when exposed to 50 mM EtOH. On the other hand, EtOH exposure did not cause any significant viability loss in Mcl-1L stable cells suggesting that stable expression of Mcl-1L isoform in neuroblastoma cells is protective against EtOH exposure.
SH-SY5Y PHFN
Overexpression of SRSF1 Recovers Toxicity Associated with EtOH Exposure
To gain more insight into the EtOH-induced suppression of SRSF1 expression, possible impact of EtOH on SRSF1 transcription was analyzed by reporter gene analysis. The SRSF1 promoter region (À1,000 to +49) was cloned into a firefly-luciferase reporter plasmid. PHFN cells were transfected with the SRSF1 reporter construct and exposed to 10, 25, 50, and 100 mM EtOH for 24 hours. The transcriptional activity of the SRSF1 promoter was analyzed by luciferase assay as described in the Materials and Methods. As shown in Fig. 5A , the basal transcriptional activity of the SRSF1 promoter was decreased significantly in a dose-dependent manner when cells were exposed to increasing concentrations of EtOH. These results suggest that EtOH exposure causes transcriptional suppression of SRSF1 gene expression in PHFN cells. To determine a possible role for SRSF1 downregulation in the suppression of the Mcl-1L isoform, SH-SY5Y cells were transiently transfected with an expression vector encoding SRSF1 in fusion with Myc/His tags. Cells were exposed to EtOH (50 mM) and analyzed by Western blot for Mcl-1L. As shown in Fig. 5B ,C, EtOH exposure caused a significant reduction in Mcl-1L expression in cells either untransfected or transfected with vector alone (compare lane 1 with lanes 2 and 3). Interestingly, Mcl-1L expression was significantly recovered by overexpression of SRSF1 (lane 4), suggesting that EtOH-mediated suppression of SRSF1 expression is involved in Mcl-1L down-regulation that may lead to the EtOH-induced toxicity. To gain more insight into the role of SRSF1 down-regulation in neuronal toxicity associated with EtOH exposure, the MTT cell viability assay was also performed in cells with SRSF1 overexpression. Interestingly, transient expression of SRSF1 with an expression vector under CMV promoter completely recovered the viability loss associated with EtOH exposure (Fig. 5D ), suggesting that EtOH-mediated suppression of SRSF1 was associated with neuronal toxicity. an essential step for genes that contain introns to create an mRNA molecule that can be processed by ribosomes for translation into the protein. Alternative splicing of premRNAs is a regulated process during gene expression that makes a significant contribution to proteomic diversity. Utilization of different potential splice sites of the premRNA in various combinations by spliceosome in the guidance of alternative splicing regulatory proteins leads to the translation of several functionally distinct protein isoforms. Regulation of splice variants in the brain can modulate protein function, which may ultimately affect behaviors associated with alcohol dependence and alcohol-mediated neurotoxicity. In this article, we have shown that EtOH exposure dysregulates expression of SRSF1 in primary human fetal neurons. Furthermore, alternative splicing of the candidate genes, which are known targets of SRSF1 and involved in apoptosis regulation, has shown an alteration in pre-mRNA splicing of myeloid cell leukemia-1 (Mcl-1) gene. Mcl-1 gene can mainly express 2 isoforms , which are regulated by alternative splicing. The premRNA of Mcl-1 can be alternatively spliced to remove exon 2, which produces shortened form of Mcl-1, named Mcl-1S, which lacks BH domains 1, 2 and transmembrane domain. While the longer gene product Mcl-1L enhances cell survival by inhibiting apoptosis, the alternatively spliced shorter gene product Mcl-1S promotes apoptosis (Bae et al., 2000; Thomas et al., 2010) . Our results suggest that EtOH exposure causes a significant decrease in the ratio of Mcl-1L/Mcl-1S by favoring pro-apoptotic Mcl-1S splicing in neuronal cells.
Mcl-1 is a pro-survival member of the Bcl-2 family that was initially identified in myeloid leukemia cells during differentiation (Kozopas et al., 1993) . Sequence analysis revealed that Mcl-1 contained 3 putative BH domains and experimentally it was found to protect against apoptosis. Germline deletion of Mcl-1 has been shown to cause periimplantation lethality at embryonic day 3.5 (Rinkenberger et al., 2000) , which is one of the few lethal phenotypes observed among Bcl-2 family members. Mcl-1 is believed to suppress apoptosis by interacting with pro-apoptotic Bcl-2 family member proteins (Youle and Strasser, 2008) . Mcl-1 shows high binding activity for Noxa (a BH3 only member of Bcl-2 family), PUMA (apoptosis regulator induced by p53), BIM (Bcl-2-like protein 11), and BMF (Bcl-2 modifying factor) (Chen et al., 2005 and Kuwana et al., 2005) . In addition to its importance in the regulation of apoptosis, Mcl-1 plays a key role in nervous system development and neuronal cell death. Neuronal precursors within the ventricular zone and newly committed neurons in the cortex are shown to express high levels of Mcl-1 (Arbour et al., 2008) . Mcl-1 up-regulation has been shown to have a role in Notch1-mediated survival of neuronal precursor cells (Oishi et al., 2004) and in the maintenance of granule cell survival during differentiation (Zhang and D'Ercole, 2004) . Heterozygous germline deletion of Mcl-1 results in increased susceptibility of neurons to seizures induced by pilocarpine (Mori et al., 2004) . Moreover, Mcl-1 plays a key role in the regulation of neuronal survival after injury (Arbour et al., 2008) .
Mcl-1 is essential for the survival of many different cell lineages, and its overexpression is associated with tumorigenesis. Therefore, it is crucial that its expression is strictly controlled. Indeed, Mcl-1 expression is regulated by transcriptional, post transcriptional, and post translational mechanisms (Mojsa et al., 2014) . Our data suggest that EtOH exposure does not impact the transcript levels of Mcl-1 but leads to altered splicing of the pre-mRNA resulting in a decrease in Mcl-1L and increase in Mcl-1S isoforms. However, these results did not exclude the possibility that post translational modifications leading to Mcl-1L isoform degradation might also be contributing to the decrease in the levels of the protein. Whether EtOH has any impact on post translational regulation of Mcl-1L or its stability remains to be elucidated.
Alternative splicing of Mcl-1 pre-mRNA has been shown to be regulated mainly by SRSF1. Down-regulation of SRSF1 expression in breast cancer cell lines was associated with decreased splicing of Mcl-1L over Mcl-1S isoform and increased susceptibility of the cancer cells to apoptosis (Gautrey and Tyson-Capper, 2012) . Consistent with these observations, our data suggest that EtOH-mediated downregulation of SRSF1 expression leads to a shift in Mcl-1L/ Mcl-1S ratio in favor of Mcl-1S splicing over Mcl-1L and may suggest a possible mechanism of neurotoxicity associated with EtOH exposure. Moreover, our data also suggest that either SRSF1 or Mcl-1L overexpression in neuronal cells during the course of EtOH exposure can rescue the cellular viability suppressed by EtOH exposure. These observations have suggested novel and key roles of SRSF1 and Mcl-1 genes in EtOH-induced neurotoxicity.
